Abbvie patent anti-TNFRSF21 (anti-TNFRSF21) is a humanized monoclonal antibody that specifically targets TNFRSF21. It can be used in treatment of cancer.
Specifictaions: Carrier Free, Recombinant, ExactAb™, Low Endotoxin, Azide Free, Validated, Animal Free, ≥95%(SDS-PAGE&SEC-HPLC), See COA
Related Documents: https://ald-pub-files.oss-cn-shanghai.aliyuncs.com/aladdinsci/pdp/sds/1/AB209901-SCI_d1008e1e1c74b50dc087adb34aaf9e1a.pdf
- UPC:
- 51111829
- Condition:
- New
- Availability:
- 5-10 days
- Weight:
- 1.09 Ounces
- HazmatClass:
- No
- WeightUOM:
- LB
- MPN:
- Ab209901-100μg
- Product Size:
- 100μg